Bipolar Disorder in Women: How Hormones Change Everything
Written by Vaishali Desai, PMHNP-BC, DNP
Bipolar disorder affects men and women at roughly equal rates — but it does not present the same way. Women are more likely to be misdiagnosed with depression for years before receiving the correct diagnosis. They have higher rates of rapid cycling, mixed features, and bipolar II. And hormonal fluctuations across the menstrual cycle, perimenopause, and the postpartum period interact with mood in ways that are clinically significant and still underappreciated in mainstream psychiatric care.
If you are a woman who has been told your mood is “just depression,” who has cycling symptoms that don't fully respond to antidepressants, or who has noticed a clear hormonal dimension to your mood — this page is for you.
Why Women Are Diagnosed Differently
The most common presentation of bipolar disorder in women is depressive episodes that are more frequent, longer, and more severe than manic or hypomanic episodes. This is the opposite of the classical bipolar presentation that research and training historically emphasized — the manic episode first, which is more characteristic of men.
When a woman presents with depression, hypomania is frequently missed. Hypomania — the elevated mood state in bipolar II — can look like periods of productivity, creativity, social engagement, and reduced need for sleep. It does not feel like illness. Patients often don't report it because it was the one time they felt okay. Providers don't ask about it because they're focused on the depressive symptoms. The result is a diagnosis of major depressive disorder — and a prescription for an antidepressant.
Antidepressant-induced cycling — when an antidepressant triggers a hypomanic or manic episode in a person with underlying bipolar disorder — is a diagnostic clue that is often missed. If someone has tried multiple antidepressants and reports that each one either stopped working, caused agitation, or made them feel “too elevated” before crashing, this pattern warrants a re-evaluation for bipolar disorder. The average delay from first symptom to correct bipolar diagnosis is nearly a decade — and women have longer delays than men.
The Hormonal Axis
Hormones don't cause bipolar disorder — but they interact with its biology in ways that shape its course in women specifically.
Estrogen and mood neuroscience
Estrogen has mood-modulating effects on both dopamine and serotonin systems. Higher estrogen levels are associated with improved mood and cognitive function; estrogen withdrawal is associated with mood instability. This is why mood symptoms often track the menstrual cycle — and why perimenopausal estrogen decline is a significant risk period.
PMDD and bipolar co-occurrence
Premenstrual dysphoric disorder (PMDD) — a distinct clinical condition involving severe mood, irritability, and anxiety in the luteal phase — co-occurs with bipolar disorder at higher rates than in the general population. When both are present, the premenstrual window can amplify bipolar cycling. Menstrual cycle charting is a clinical tool that helps identify whether mood episodes are cycling independently of or in sync with the hormonal cycle.
Perimenopause
The perimenopausal transition — often spanning years before the final menstrual period — is a high-risk window for new-onset mood episodes or destabilization of previously well-managed bipolar disorder. The hormonal volatility of this period (estrogen fluctuating widely before declining) can dysregulate mood even in women who have been stable for years. Providers who are not tracking hormonal status in perimenopausal women with bipolar disorder are missing a clinically important variable.
Postpartum as the highest-risk window
The postpartum period is the single highest-risk time for a first manic episode in people with underlying bipolar disorder. The dramatic estrogen and progesterone crash at delivery, combined with sleep deprivation, is a potent trigger. Women with bipolar disorder (or a family history) should have a postpartum psychiatric monitoring plan in place before delivery — not after symptoms appear.
Rapid Cycling and Mixed Features
Two clinical features that occur disproportionately in women — rapid cycling and mixed features — are also among the most difficult to treat and the most dangerous to miss.
Rapid cycling
Rapid cycling is defined as four or more distinct mood episodes in a 12-month period. Women have significantly higher rates of rapid cycling than men. Antidepressant use without concurrent mood stabilization is one of the most common drivers of antidepressant-induced rapid cycling — another reason why accurate diagnosis matters before treatment is started.
Mixed features
A mixed features episode — depression and elevated or irritable mood occurring simultaneously — is more common in women and more dangerous than either a pure depressive or pure manic episode. The combination of low mood and high activation produces significant impulsivity and elevated suicide risk. Patients often describe this as feeling “depressed and wired” simultaneously — agitated, racing thoughts, unable to sleep, but deeply hopeless. This pattern, when present, is a clinical warning sign that warrants urgent attention and reconsideration of the treatment plan.
Written by a PMHNP-BC
Understanding Bipolar Disorder & Your Medication
A complete guide to bipolar disorder — what it is, how medications work, mood stabilizer options, and how to have a productive conversation with your prescriber. Written by Vaishali Desai, PMHNP-BC, DNP.
⚡ Instant download — available immediately after purchase
Mood Stabilizers and Reproductive Health
For women of childbearing age, the choice of mood stabilizer is not just a psychiatric decision — it is a reproductive health decision. Some of the most effective mood stabilizers carry significant teratogenic risks that make them contraindicated or require careful counseling for women who might become pregnant.
Valproate (Depakote): the critical warning
Valproate is highly effective for bipolar disorder — and highly teratogenic. It is associated with neural tube defects, cognitive impairment, autism spectrum features, and other structural abnormalities in infants exposed in utero. It should be avoided in reproductive-age women unless all other options have been exhausted and effective contraception is in place. European regulatory agencies have issued significant restrictions on valproate use in women of childbearing potential. This is a conversation every prescriber should be having with female patients before starting this medication.
Lithium
Lithium has the most evidence for bipolar treatment overall, and its safety data in pregnancy is more nuanced than once believed. Earlier concerns about cardiac defects (Ebstein's anomaly) appear to be less common than initially reported. Lithium use in pregnancy requires careful dose monitoring — blood levels shift significantly across trimesters. Breastfeeding on lithium requires monitoring of infant levels. These are manageable but require a prescriber who is actively following the pregnancy.
Lamotrigine (Lamictal)
Lamotrigine is often the preferred mood stabilizer for women of childbearing age, particularly for bipolar II where depressive episodes predominate. It has a relatively favorable reproductive safety profile. However, there is a critical drug interaction: hormonal contraceptives (estrogen-containing) can significantly lower lamotrigine levels — sometimes by 50% — which can precipitate breakthrough mood episodes. This interaction is frequently not discussed at prescription. Women on lamotrigine should explicitly ask their prescriber about this if they are using or planning to use hormonal birth control.
Reproductive counseling as standard of care
Reproductive counseling — discussing contraception, pregnancy planning, and medication safety before pregnancy occurs — should be a standard part of care for any woman of childbearing age with bipolar disorder. The time to have this conversation is not when a patient calls to say she just found out she is pregnant.
Living Well With Bipolar Disorder
Bipolar disorder is a lifelong condition. Stability is achievable — but it requires a more active approach than most other psychiatric conditions, because the illness will exploit any opening created by disrupted routines.
Sleep as the #1 mood stabilizer
Sleep disruption is both a prodromal sign of mood episodes and a trigger for them. Circadian rhythm dysregulation can independently destabilize bipolar disorder. Protecting sleep — consistent bedtimes, limiting shift work, managing late-night social obligations — is a clinical intervention, not a wellness suggestion.
Social Rhythm Therapy (IPSRT)
Interpersonal and Social Rhythm Therapy (IPSRT) is an evidence-based psychotherapy specifically designed for bipolar disorder. It focuses on stabilizing daily social rhythms — consistent meal times, activity schedules, sleep-wake cycles — alongside addressing interpersonal stressors. Multiple randomized trials support its effectiveness in reducing episode recurrence.
Recognizing prodromal symptoms
Most people with bipolar disorder have consistent early warning signs before a full episode — specific sleep changes, specific thought patterns, specific behaviors. Identifying and monitoring personal prodromal symptoms — ideally with a mood chart — allows for early intervention before episodes become full-blown.
Medication adherence
Stopping mood stabilizers is associated with a 90% relapse rate within 18 months. This is not a scare tactic — it is a well-documented finding across the bipolar literature. The periods when people most want to stop medication (feeling well, missing their elevated states, side effects) are also the periods when stopping is most likely to cause harm. Discussions about stopping or adjusting medication should involve a prescriber and a careful tapering plan.
Prescriber Conversation Guide
Women with bipolar disorder often have to be their own advocates to get care that accounts for the hormonal dimension of their illness. These questions help start those conversations.
- “Is my cycling pattern typical for bipolar, or does it track my menstrual cycle? Should I be keeping a mood and cycle chart?”
- “How does my birth control affect my mood stabilizer? Specifically, does it change lamotrigine levels?”
- “What should I do if I want to get pregnant — what's the safest medication option, and how far in advance should we be planning?”
- “I'm entering perimenopause — how does that affect my bipolar disorder, and should we adjust my treatment plan?”
- “I've been on antidepressants without a mood stabilizer. Could that be contributing to cycling?”
From the clinic: “Women with bipolar are often told they're ‘just dramatic’ for years before getting the right diagnosis. The depressive episodes get treated with antidepressant after antidepressant that doesn't hold. The hormonal piece isn't an excuse — it's a clinical reality that changes how we diagnose and treat this condition. When someone finally gets the right diagnosis and the right medication, the change can be profound.” — Vaishali Desai, PMHNP-BC, DNP
Vaishali Desai, PMHNP-BC, DNP is a Board-Certified Psychiatric Mental Health Nurse Practitioner with nearly 10 years of clinical experience in mental health. She is the founder of 360 Mental Healing LLC and 360 Mind Shop, created to give patients and families the clinical information they deserve in language they can actually use.
This content is for educational purposes only and does not constitute medical advice. It is not a clinical assessment or a provider-patient relationship. Always consult your licensed healthcare provider before starting, stopping, or changing any medication or treatment plan. If you are experiencing a psychiatric emergency, call or text 988 or go to your nearest emergency room.
Complete Mental Health Library — All 19 Core Guides
Every guide Vaishali has written — medications, diagnoses, treatments, and life transitions — in one complete library. Instant download, written for real people navigating real mental health challenges.